PURE Bioscience, Inc. announced earnings results for the first quarter ended October 31, 2020. For the first quarter, the company announced total revenue was USD 1.591 million compared to USD 398,000 a year ago. Operating loss was USD 179,000 compared to USD 1.130 million a year ago. Net loss was USD 180,000 compared to USD 1.125 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.